Delivery Order SPE2DB20D3111-SPE2DB25FA9EU
- Not listed
- The Defense Logistics Agency awarded a $3,574.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Botox Cosmetic 100-unit vials, with an ultimate completion date of September 8, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, valued at $3,574.80 with a completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,362.20 on September 4, 2025, for the supply of BOTOX Cosmetic 100-unit vials, with an ultimate completion date of September 25, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, valued at $3,419.20, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $12,045.00 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX on August 1, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,838.32 on June 18, 2025, for the supply of Botox 200 Unit Vials, with completion expected by July 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The award carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of BOTOX Cosmetic 100-unit vials with a ceiling value of $1,787.40. This firm fixed-price delivery order, which is expected to be completed by October 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract was competitively awarded without set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $3,011.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox, with an ultimate completion date of August 19, 2025. The contract, which was competitively awarded with no set-aside designation, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,574.80 on September 15, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, with an ultimate completion date of October 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a $15,639.75 delivery order to AmerisourceBergen Drug Corp for the supply of BOTOX Cosmetic 100 unit vials. This competitively awarded, firm fixed-price contract with no set-aside designation is expected to be completed by October 3, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9EUDelivery Order
The Defense Logistics Agency awarded a $3,574.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Botox Cosmetic 100 Unit vials, with an ultimate completion date of September 24, 2025. This is a non-set-aside contract issued on September 3, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement across military and veteran healthcare systems. This delivery order falls within AmerisourceBergen's comprehensive $999.9 billion IDC with DLA Troop Support Medical (designated SPE2DX), which runs through December 2026 and supports global pharmaceutical supply to military healthcare programs worldwide. The contract vehicle enables the company to supply a broad range of pharmaceuticals and medical supplies to customers including the Defense Health Agency and U.S. Coast Guard. The award of this Botox Cosmetic order demonstrates the vendor's role in fulfilling specialized pharmaceutical requirements for federal medical supply chains through competitive, firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/3/25 |